Treatment guidelines for depression in the Asia Pacific region: A review of current developments

Australasian Psychiatry

Volumn 12, Issue SUPPL., 2004, Pages

  Hickie, Ian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Depression; Quality Improvement; Treatment guidelines

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; NEUROLEPTIC AGENT; PAROXETINE; VENLAFAXINE;

ASIA; AUSTRALIA; CHINA; CLASSIFICATION; CLINICAL PATHWAY; CONSENSUS DEVELOPMENT; CULTURAL FACTOR; GOVERNMENT; HEALTH CARE QUALITY; HEALTH SURVEY; HONG KONG; HUMAN; JAPAN; KOREA; MAJOR DEPRESSION; MALAYSIA; MEDICAL ASSESSMENT; MEDICAL PRACTICE; MEDICAL PROFESSION; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; REVIEW; SYSTEMATIC REVIEW; THAILAND;

EID: 5644292383     PISSN: 10398562     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1039-8562.2004.02100.x-i1     Document Type: Review

References (23)

1. Buekens P, Keusch G, Belizan J, Ahmed Bhutta Z. Evidence-based global health. JAMA 2004; 291: 2639-2641.
2. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001; 286: 2578-2585.
3. The Quality Assurance Project. A treatment outline for depressive disorders. Australian and New Zealand Journal of Psychiatry 1983; 17: 129-148.
4. Griffiths KM, Christensen H. The quality and accessibility of Australian depression sites on the World Wide Web. Medical Journal of Australia 2002; 176 (Suppl. May 20): S97-S104.
5. Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression by using the Internet: randomised controlled trial. BMJ 2004; 328: 265-269.
6. Hickie IB, on behalf of beyondblue: the national depression initiative. 'Can we reduce the burden of depression? The Australian experience with beyondblue: the national depression initiative. Australasian Psychiatry 2004 (in press).
7. Littlejohns P, Cluzeau F, Bale R, Grimshaw J, Feder G, Moran S. The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK. British Journal of General Practice 1999; 49: 205-210.
8. National Health and Medical Research Council (NHMRC). Guidelines for the Development and Implementation of Clinical Practice Guidelines. Canberra: NHMRC, 1995.
9. World Health Organization World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-2590.
10. Ellis PM, Smith DAR. Treating depression: the beyondblue guidelines for treating depression in primary care. Medical Journal of Australia 2002; 176(Suppl. May 20): S77-S83.
11. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. Australian and New Zealand clinical practice guidelines for the treatment of depression. Australian and New Zealand Journal of Psychiatry 2004; 38: 389-407.
12. The AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument: September 2001. Available at URL: http://www.agreecollaboration.org. Accessed August 2004.
13. Hickie I, Groom G. Primary care-led mental health service reform: an outline of the Better Outcomes in Mental Health-Care initiative. Australasian Psychiatry 2002; 10: 376-382.
14. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Australian and New Zealand Journal of Psychiatry 2004; 38: 280-305.
15. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. American Journal of Psychiatry 1993; 150 (Suppl. 4): S1-S26.
16. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 2000; 157 (Suppl. 4): S1-S45.
17. Canadian Psychiatric Association. Clinical guidelines for the treatment of depressive disorders. Canadian Journal of Psychiatry 2001; 46 (Suppl). 1: S1-S90.
18. Lee MS. Korean Medication Algorithm Project for Major Depressive Disorder (KMAP-MDD). Executive Committee, KMAP-MDD, Korean Society of Depressive and Bipolar Disorders, 2003.
19. Ministry of Health. National Center of Mental Health China - CDC. China Guideline for Prevention and Treatment of Depression (Draft). China: Chinese Society of Psychiatry, Peking University Institute of Mental Health, 2003.
20. Boonyawongvirot P (ed.) Mental Health in Thailand 2002-2003. Thailand: Department of Mental Health, Ministry of Public Health, 2003.
21. Lee S, Yu H, Wing Y, Chan C et al. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. American Journal of Psychiatry 2000; 157 380-384.
22. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S. Reducing the global burden of depression. Population-level analysis of intervention cost-effectiveness on 14 world regions. British Journal of Psychiatry 2004; 184: 393-403.
23. Hickie IB, Scott EM, Davenport TA. Enhancing the evidence base for clinical psychiatry: are practice surveys a useful tool? Medical Journal of Australia 1999; 171: 315-318.